 오퍼게시판 |
|
|
제 목:
|
Semaglutide |
|
등록분류: |
Offer to Sell |
|
내용: |
CAS NO: 910463-68-2
Additional_detail: Semeglutide is a long-acting glucagon-like peptide 1 (GLP-1) analog, a GLP-1 receptor agonist, and has potential therapeutic efficacy in type II diabetes mellitus (T2DM).
Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.
*Products under the patent are only for R&D use.
|
연락처 |
| 담
당 자: |
Xie Wen Feng |
| 회사주소: |
16/F,Huicheng Comm,Complex,No839 XiaHe Rd, Xiamen,China |
| 전화번호: |
+86-592-5881089 |
| 팩스번호:
|
+86-592-5854960 |
| E - mail: |
xie@china-sinoway.com |
|
현재위치
: Home > Trade 
